Pre-transplant imatinib improved clinical outcomes in Ph+ALL patients undergoing HSCT

  • April 21, 2014

Pre-transplant imatinib appears to improve clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.

In the retrospective study, researchers assessed data of 738 patients with Ph+ALL who were treated with HSCT between 1990 and 2010. Information about these patients was gleaned from the Transplant Registry Unified Management Program of the Japan Society of Hematopoietic Cell Transplantation.

Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

More»
More»
More»
  • Health Care Update
  • ARNOLD AND PORTER SILO
  • PQRS interim claims
  • 2013 PQRS interim claims feedback data now available for individual eligible professionals. Analysis by Catherine Brandon of Arnold & Porter LLP.
More »
  • Financial Planning
  • RUDZINSKI COLUMN
  • Advice for physicians
  • Be aware of important 2014 IRA updates. Analysis by Certified Financial Planner Ken Rudzinski.
More »
HemOnc Today